FDA Approved: LEVALBUTEROL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for levalbuterol by Mylan Pharmaceuticals, approving a change to the product under ANDA 078309.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Levalbuterol (Levalbuterol)

Snippet

SUPPL AP for LEVALBUTEROL (LEVALBUTEROL)